Feldan Therapeutics secured Series C financing with GC Holdings, Stonebridge Ventures, Anges Québec Capital, members of Anges Québec, and existing investors
Ampersand Capital Partners, in partnership with NEOMED-LABS management, acquired NEOMED-LABS Inc. from its not-for-profit founder and parent, the NEOMED Institute
New Water Capital acquired Brockville's Trillium Health Care Products, a premier contract manufacturer of category-leading OTC products for pharmaceutical companies.
Emblem (TSX-V: EMC; OTCPK: EMMBF) signed a non-binding Letter of Intent to acquire Natura Naturals in a cash-stock deal valued at $76M (inclusive of shares already owned by Emblem).
Privateer Holdings' Tilray priced its initial public offering (IPO) at US $17 per share, above its proposed price range for gross proceeds of US $153 million
We produce great contents and rely solely on subscription and online advertisements to fund our research and news operations.
We hate intrusive, popup and other annoying ads too and you will not find them at our sites.
If you like our contents, please disable ad-blocking for this site AND refresh to continue.
Thank you for your support!
Subscribers: we are ads-free to our subscribers; please disable ad-blocker to properly access subscriber management function (required).
